Table 5. Skin Self-examination (SSE) Practices in the Past Year for People Treated for Localized Melanomaa.
| SSE Practices | % (95% CI) | |
|---|---|---|
| Without Recurrence or New Primary (n = 230)b | With Recurrence or New Primary (n = 32) | |
| Frequency of SSE | ||
| Weekly | 8 (6-12) | 16 (5-33) |
| Fortnightly | 7 (5-11) | 3 (0.1-16) |
| Monthly | 23 (18-28) | 9 (2-25) |
| Every 2 mo | 10 (7-14) | 6 (1-21) |
| Every 3 mo | 9 (6-13) | 9 (2-25) |
| Longer than 3-mo intervals | 14 (10-19) | 9 (2-25) |
| Did not perform SSE | 30 (25-35) | 47 (29-65) |
| Who performed SEE | ||
| Self | 24 (19-30) | 9 (2-25) |
| Family member | 4 (2-8) | 6 (1-21) |
| Self and family member | 42 (36-48) | 38 (21-56) |
| Did not perform SSE | 30 (25-35) | 47 (29-65) |
| Examines all body parts, including hard-to-see areasc | 44 (38-50) | 31 (16-50) |
| Examines skin with a full-length mirrord | 53 (47-59) | 42 (25-61) |
| Confidence to detect recurrent or new primary melanoma | ||
| Very confident | 9 (6-13) | 6 (1-21) |
| Confident | 30 (24-35) | 34 (19-53) |
| Not entirely confident | 25 (20-31) | 13 (4-29) |
| Not at all confident | 7 (5-11) | 0 |
| Did not perform SSE | 30 (24-35) | 47 (29-65) |
a
Percentages are of column totals.
b
Adjusted for our oversampling of stage II patients to be potential participants. This adjustment means that our estimates more accurately represent the skin self-examination practices for the full cohort of patients (rather than being unduly influenced by stage II patients).
c
Missing data for a participant without recurrence or new primary melanoma (n = 1).
d
Missing data for a participant with recurrence or new primary melanoma (n = 1).